Same Indication

Osimertinib vs Sars-Cov-2 Virus Spike Protein

Osimertinib vs Sars-Cov-2 Virus Spike Protein: Overview

This comparison examines the pharmacological differences between Osimertinib and Sars-Cov-2 Virus Spike Protein.

Mechanism of Action

Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

Pharmacokinetics

Half-life: Osimertinib — 48 hours.

Chemical Properties

Molecular Formula: Osimertinib — C28H33N7O2.

Molecular Weight: Osimertinib — 499.6050 g/mol.

Type: Osimertinib — Small molecule; Sars-Cov-2 Virus Spike Protein — Vaccine component.